Lenz & Staehelin advised Holcim (Suisse) SA in this transaction. Holcim (Suisse) SA, the Swiss entity of the Holcim Group, announced its acquisition of the group...
Holcim Suisse SA’s Acquisition Of Cand-Landi
Transmutex’s CHF20 Million Series A Financing Round Extension
Lenz & Staehelin advised Transmutex on all legal matters. Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20M in the extension...
Ferrer’s Progressive Supranuclear Palsy (PSP) License Agreement with Asceneuron
Lenz & Staehelin advised Asceneuron in this transaction. Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing...
Gyrus Capital’s Acquisition of Consulcesi Group
Lenz & Staehelin advised Gyrus Capital in this transaction, alongside with Chiomenti (Italian law) and Wolf Theiss (Albanian law). Consulcesi and Falcon Industrial was advised by...
Beqom’s $300 Million Investment From Sumeru
Lenz & Staehelin advised beqom SA in this transaction, while Walkers and Weil, Gotshal & Manges LLP assisted Sumeru Equity Partners. beqom, a company sponsored inter...
Essential Pharma’s Acquisition of Ocular And Postpartum Therapies From Novartis
Lenz & Staehelin advised Essential Pharma in this transaction. Essential Pharma, a portfolio company of Gyrus Capital, has acquired on December 8, 2021, the worldwide rights...